Diversified Trust Co increased its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 5.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,997 shares of the semiconductor company’s stock after purchasing an additional 163 shares during the period. Diversified Trust Co’s holdings in Synopsys were worth $1,518,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also added to or reduced their stakes in SNPS. ORG Partners LLC lifted its holdings in shares of Synopsys by 600.0% during the second quarter. ORG Partners LLC now owns 42 shares of the semiconductor company’s stock worth $25,000 after buying an additional 36 shares in the last quarter. University of Texas Texas AM Investment Managment Co. acquired a new stake in Synopsys in the 4th quarter worth about $28,000. Chris Bulman Inc bought a new stake in Synopsys in the 2nd quarter valued at about $30,000. Fortitude Family Office LLC grew its position in shares of Synopsys by 66.7% during the 2nd quarter. Fortitude Family Office LLC now owns 60 shares of the semiconductor company’s stock worth $36,000 after purchasing an additional 24 shares in the last quarter. Finally, Hazlett Burt & Watson Inc. increased its holdings in shares of Synopsys by 40.0% during the first quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $40,000 after purchasing an additional 20 shares during the period. 85.47% of the stock is currently owned by institutional investors.
Synopsys Stock Up 4.6 %
NASDAQ SNPS opened at $517.76 on Wednesday. The company has a market cap of $79.33 billion, a price-to-earnings ratio of 55.53, a price-to-earnings-growth ratio of 3.28 and a beta of 1.08. Synopsys, Inc. has a twelve month low of $448.91 and a twelve month high of $629.38. The business’s fifty day moving average is $511.05 and its 200 day moving average is $551.13.
Insider Buying and Selling at Synopsys
In other news, insider Geus Aart De sold 493 shares of Synopsys stock in a transaction on Monday, July 15th. The shares were sold at an average price of $620.60, for a total transaction of $305,955.80. Following the transaction, the insider now owns 106,983 shares in the company, valued at approximately $66,393,649.80. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CEO Sassine Ghazi sold 10,293 shares of the firm’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $553.89, for a total transaction of $5,701,189.77. Following the completion of the transaction, the chief executive officer now directly owns 62,568 shares in the company, valued at $34,655,789.52. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Geus Aart De sold 493 shares of the company’s stock in a transaction that occurred on Monday, July 15th. The shares were sold at an average price of $620.60, for a total value of $305,955.80. Following the completion of the sale, the insider now owns 106,983 shares in the company, valued at $66,393,649.80. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.66% of the company’s stock.
Analysts Set New Price Targets
A number of equities research analysts recently issued reports on the company. Needham & Company LLC reissued a “buy” rating and set a $640.00 price target on shares of Synopsys in a research report on Thursday, August 22nd. Robert W. Baird increased their target price on Synopsys from $661.00 to $663.00 and gave the stock an “outperform” rating in a report on Thursday, August 22nd. Piper Sandler restated an “overweight” rating and issued a $687.00 price target on shares of Synopsys in a research report on Thursday, August 22nd. KeyCorp upped their price objective on shares of Synopsys from $675.00 to $690.00 and gave the stock an “overweight” rating in a research report on Thursday, June 27th. Finally, Rosenblatt Securities reissued a “buy” rating and issued a $635.00 target price on shares of Synopsys in a report on Friday, August 23rd. Ten research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $638.00.
View Our Latest Stock Analysis on SNPS
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- The Basics of Support and Resistance
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- 5 discounted opportunities for dividend growth investors
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.